BioXmark ® liquid fiducial markers for image guided radiotherapy in muscle invasive bladder cancer, a safety and performance trial.

CONCLUSION: The success rate of this novel fiducial marker was 79% which is above the prospectively defined threshold rate. A distinct learning curve of the injection of the liquid marker was seen over the study period. The marker showed sustained visibility and positional stability during treatment phases and also appears to be safe and easy to inject.
ADVANCES IN KNOWLEDGE: This novel liquid BioXmark® marker seem to be a very promising tool in daily-adaptive IGRT for bladder preserving chemo-radiotherapy in muscle invasive bladder cancer.
PMID: 32463291 [PubMed - as supplied by publisher]

Source: The British Journal of Radiology - May 27, 2020 Category: Radiology Authors: de Ridder M, Gerbrandy LC, de Reijke TM, Hinnen KA, Hulshof MCCM Tags: Br J Radiol Source Type: research